Charles Albright, EVP/Chief Scientific Officer at Editas Medicine, Inc. (EDIT), sold 19,800 shares at $62.74 ($1.3M) on 2020-12-15, disclosed to the SEC on 2020-12-17.
Open-market sale of $1.3M EDIT by EVP/Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.74 | 5,776 | $362K | 29.0% |
| 2 | $62.74 | 5,776 | $362K | 29.0% |
| 3 | $63.84 | 4,024 | $257K | 20.5% |
| 4 | $63.84 | 4,024 | $257K | 20.5% |
| 5 | $64.39 | 200 | $13K | 1.0% |
| Total | $63.20 avg | 19,800 |
| $1.3M |
| 100% |
| Filing → |
| EDIT | SELL | 2020-11-10 | $7K | — | Filing → |
| EDIT | SELL | 2020-10-16 | $94K | — | Filing → |
| EDIT | SELL | 2020-08-19 | $353K | — | Filing → |